Population distribution of xeroderma pigmentosum

Advances in Experimental Medicine and Biology

Volumn 637, Issue , 2008, Pages 138-143

  Bhutto, Abdul Manan ^a   Kirk, Sandra H ^b  

^a Shaheed Mohtarama Benazir Bhutto Medical University   (Pakistan)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CONSANGUINITY; DNA REPAIR; EARLY DIAGNOSIS; EXCISION REPAIR; GENE FREQUENCY; GENE MUTATION; GENETIC COMPLEMENTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HUMAN; INCIDENCE; LATITUDE; MELANOMA; MORTALITY; NEUROLOGIC DISEASE; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNLIGHT; TRICHOTHIODYSTROPHY; WEATHER; XERODERMA PIGMENTOSUM; POPULATION GENETICS;

DNA REPAIR; GENETICS, POPULATION; HUMANS; XERODERMA PIGMENTOSUM;

EID: 60549107714     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-09599-8_15     Document Type: Review

References (59)

1. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968; 218:652-656.
2. Cleaver JE. DNA damage and repair in light-sensitive human skin disease. J Invest Dermatol 1970; 54:181-195.
3. Cleaver JE, Carter DM. Xeroderma pigmentosum variants: influence of temperature on DNA repair. J Invest Dermatol 1973; 60:29-32.
4. Hebra F, Kaposi M. On diseases of the skin including the exanthemata. Vol 3 Tay W, trans. London. The New Sydenham Society 1874; 61:252-258.
5. Robbins JH, Kraemer KH, Lutzner MA et al. Xeroderma Pigmentosum: an inherited disease with sun sensitivity, multiple cutaneous neoplasms and abnormal DNA repair. Ann Inter Med 1974; 80:221-248.
6. Ncel JV, Kod ai M, Brewer R et al. The incidence of consanguineous matings in Japan: with remarks on the estimation of comparative gene frequencies and the expected rate of appearance of induced recessive mutations. Am J Hum Genet 1949; 1:156-178.
7. Thielmann HW, Edler L, Popanda O et al. Xeroderma pigmentosum patients from the federal repubhc of Germany: decrease in post-UV colony-forming abiUty in 30 xeroderma pigmentosum fibroblast strains is quantitatively correlated with a decrease in DNA-incising capacity. J Cancer Res Clin Oncol 1985; 109:227-240.
8. Kraemer KH. Heritable diseases with increased sensitivity to cellular injury. In: Fatzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine, 4th ed. New York: McGraw-Hill, 1993:1974.
9. Takcbe H, Nishigori C and Satoh Y. Genetics and skin cancer of xeroderma pigmentosum in Japan. Jpn J Cancer Res (Gann) 1987; 78:1135-1143.
10. Jung EG. Xeroderma Pigmentosum. Int J Dermatol 1986; 25:629-633.
11. Hashcm N, Bootsma D, Keijzer W et ai. Clinical characteristics, DNA repair and complementation groups in xeroderma pigmentosa patients from Egypt. Cancer Res 1980; 40:13-18.
12. Fischer E, Ihielmann HW, Neundorfer B at al. Xeroderma pigmentosum patients from Germany: Clinical symptoms and DNA repair characteristics. Arch Dermatol Res 1982; 274:229-247.
13. Pawsey SA, Magnus LA, Ramsay CA. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum. Qurat J Med 1979; 190:179-210.
14. Kraemcr KH, Slor H. Xeroderma pigmentosum. Clin Dermatol 1985; 3:33-69.
15. Hwang SW, Yoo YE, Kim YP. The genetics and clinical studies of xeroderma pigmentosum. Korean J Dermatol 1982; 20:879-884.
16. Park SD, Chung HY. Characterization of a Korean xeroderma pigmentosum cell strain, XPISE, by somatic cell hybridization and complementation studies. Korean J Genetic 1982; 4:69-78.
17. Jiang Z, Hu Y, Chen Q e t al. Study of DNA repair enzyme system. 1. Ultraviolet induced H-TdR unscheduled incorporation in xeroderma pigmentosum lymphocytes. Acta Genet. Sin 1981; 8:310-315.
18. Goyal JL, Rao VA, Srinivasan R et al. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 1994; 78:295-297.
19. Bhutto AM, Shaikh A, Nonaka S. Incidence of xeroderma pigmentosum in Larkana, Pakistan. Br J Dermatol 2005; 152:545-551.
20. Bouadjar B, Ait-Belkacem F, Daya-Grosjean L et al. Xeroderma pigmentosum. A study in 40 Algerian patients. (Article in French) Ann Dermatol Venereol 1996; 123:303-306.
21. Khatri ML, Shafi M, Mashina A. Xeroderma pigmentosum. A clinical study of 24 Libyan cases. J Am Acad Dermatol 1992; 26:75-78.
22. Moussaid L, Benchikhi H, Boukind EH et al. Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients. Ann Dermatol Venereol 2004; 131:29-33.
23. Jacyk WK. Xeroderma pigmentosum in black Sounth Africans. Int J Dermatol 1999; 38:511-514.
24. Fazaa B, Zghal M, Bailly C et al. Melanoma in xeroderma pigmentosum: 12 cases. Ann Dermatol Venereol 2001; 128(4):503-506.
25. Kato T, Akiba H, Seiji M et al. Clinical and biological studies of 26 cases of xeroderma pigmentosum in northeast district of Japan. Arch Dermatol Res 1985; 277:1-7.
26. Kanda T, Oda M, Yonezawa M et al. H. Peripheral neuropathy in xeroderma pigmentosum. Brain 1990; 113:1025-1044.
27. Swift M, Chase C. Cancer in families with xeroderma pigmentosum. J Natl Cancer Inst 1979; 218:652-656.
28. Thompson LH. Nucleotide excision repair: Its relation to human disease. In: Nickoloff JA, Hoekstra M, eds. DNA Repair in Higher Eukaryotes. Totowa: Humana Press, 1998; Vol 2; pp 335-393.
29. Svoboda DL, Briley LP, Vos J-HM. Defective bypass replication of a leading strand cyclobutane thymine dimcr in xeroderma pigmentosum variant cell extracts. Cancer Research 1998; 58:2445-2448.
30. Cleaver JE, Kraemer KH. Xeroderma Pigmentosum and Cockayne Syndrome. In: The metabolic and molecular bases of inherited disease, 7th ed, edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-HiU, 1995; Vol III, pp 4393-4419.
31. Kohyama J, Furushima W, Sugawara Y et al. Convulsive episodes in patients with group A xeroderma pigmentosum. Acta Neurol Scand 2005; 112(4):265-269.
32. Nishigori C, Moriwaki S, Takebe H et al. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Arch Dermatol 1994; 130:191-197.
33. Kore-eda S, Tanaka T, Moriwaki S et al. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Arch Dermatol 1992; 128:971-974.
34. Tanioka M, Budiyant A, Ueda T et al. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A. J Invest Dermatol 2005; 125(2):244-2446.
35. Scott RJ, Itin P, Kleijer WJ et al. Xeroderma pigmentosum-Cockayne sundrome complex in two patients: Absence of skin tumors despite severe deficiency of DNA excision repair. J Am Acad Dermatol 1993; 29:883.
36. Weeda G, Evano E, Donker I et al. A mutation in the XPB/ERCC3 DNA repair transcripyion gene, associated with trichothiodystrophy. Am J Hum Genet 1997; 60:320.
37. Thielmann HW, Popanda O, Edler L et al. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany. Cancer Res 1991; 51:3456.
38. Kondo S et al. Late onset of skin cancers in 2 xeroderma pigmentosimi group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F. Photodermatology 1989; 6:89.
39. Vermeulen W, Stefanini M, Giliani S et al. Xeroderma pigmentosum complementation group H falls into complementation group D. Mutat Res 1991; 255:201.
40. Broughton BC, Thompson AF, Harcourt SA ct al. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and cockayne syndrome. Am J Hum Genet 1995; 56:167-174.
41. Yin J, Li J, Ma Y et al. The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population. Cancer Lett 2005; 223(2):219-226.
42. Brewster AM, Alberg AJ, Strickland PT et al. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2004; 13(8):1271-1275.
43. Yamamura K, Ichihashi M, Hiramoto T et aL Clinical and photobiological characteristics of xeroderma pigmentosum complementation group F: a review of cases from Japan. Br J Dermatol 1989; 121:471-480.
44. Jaspers NG, Raams A, Silengo MC et al. First reported patient with human ERCCl deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet 2007; 80(3):457-466.
45. Arlett CF, Harcourt SA, Lehmann AR et aL Studies of a new case of xeroderma pigmentosum (XP3BR) from complementation group G with cellidar sensitivity to ionizing radiation. Carcinogenesis 1980; 1:745.
46. Jaeken J et al. Clinical and biochemical studies in three patients with severe early infantile Cockayne syndrome. Hum Genet. 1989; 83:339.
47. Moriwaki S, Stefanini M, Lehmann AR et al. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and Cockayne syndrome resemble xeroderma pigmentosum cells. J Dermatol Invest 1996; 107:647.
48. Mamada A, Miura K, Tsunoda K et al. Xeroderma pigmentosum variant associated with multiple skin cancers and a lung cancer. Dermatology 1992; 184:177-181.
49. Somos S, Schneider I, Rasko I. Xeroderma pigmentosum variant or pigmented xerodermoid. Anticancer Res 1997; 17:753-756.
50. Kraemer KH, Lee MM andrews AD et aL The role of sunUght and DNA repair in melanoma and nonmelanoma sldn cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994; 130:1018-1021.
51. de Sa BC, Rezze GG, Scramim AP et aL Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients. Melanoma Res 2004; 14(6):487-492.
52. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123:241-250.
53. Stiller CA. International variations in the incidence of childhood carcinomas. Cancer Epidemiol Biomarkers Prev 1994; 3(4):305-310.
54. Varan A, Gokoz A, Akyuz C et al. Primary malignant skin tumors in children: etiology, treatment and prognosis. Pediatr Int 2005; 47(6):653-657.
55. Chidzonga MM. Lip cancer in Zimbabwe. Int J Oral Maxillofac Surg 2005; 34(2): 149-151.
56. Johnson MW, Skuta GL, Kincaid MC et al. Malignant Melanoma of the iris in xeroderma pigmentosum. Arch Ophthalmol 1989; 107:402-407.
57. Weiss JM, Weiss NS, Ulrich CM et al. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol Oncol 2006; 103(3):891-896.
58. English JSC, Swerdlow AJ. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987; 117:457-461.
59. Pippard EC, Hall AJ, Barker DJ ct al. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988; 48(10):2929-2932.